Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy
Sponsored by Bausch Health Americas, Inc.
About this trial
Last updated 6 years ago
Study ID
3200A3-1110
Status
Withdrawn
Type
Interventional
Phase
Phase 1
Placebo
No
Accepting
18 to 65 Years
All
Trial Timing
Ended 18 years ago
What is this trial about?
To evaluate the effects of single oral doses of MOA-728 compared to a positive control in
subjects on methadone therapy.
What are the Participation Requirements?
Inclusion:
1. Healthy men or women, aged 18 to 65 years.
2. History of methadone treatment for at least 1 month, at a dose >=30 and <=140 mg/day.
Exclusion:
1. History or active presence of clinically important medical disease.
2. Allergy to opioids.